AbbVie to invest €60m as company’s Cork facility marks 20th anniversary
AbbVie (NYSE: ABBV), global research and development-based biopharmaceutical company with a significant presence across 8 Irish locations, announced a €60 million investment at its manufacturing site in Cork. The expansion, which will include the development of a new state-of-the-art facility, will create approximately 70 new jobs. New technologies will be introduced to the site in … Read more